Bora Wins Prestigious CDMO Leadership Awards
TAIPEI, TAIWAN, March 20, 2025 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, today celebrated winning three Outsourced Pharma Leadership Awards: Best New or Transformed CDMO, Biologics – Global, and Small Molecule Dosage Form – Global. The awards were presented at a ceremony at The POOL in mid-town Manhattan, New York City, on March 19.
“CDMOs are essential to the life sciences industry, and we are delighted and deeply honored to have been recognized with three prestigious CDMO Leadership Awards amongst such strong peers,” commented J.D. Mowery, president of Bora’s CDMO business. He added, “These awards are recognition of the dedication to quality and our customers that Bora colleagues around the globe demonstrate daily. This dedication is present not only in the therapies we help our customers deliver but also in our growth and investment strategies that continue to transform the Bora business to better serve our clients and patients worldwide. Thank you to our Bora team, our customers, and the teams at Outsourced Pharma and Life Science Connect for this recognition.”
Marc Goemans, Chief Commercial Officer of Bora Biologics, added, “We are honored to receive the CDMO Leadership Award for Biologics – Global. This recognition reflects our unwavering commitment to quality and innovation, exemplified by commercially-approved biosimilars in the U.S. and Canada, and our FDA-registered GMP facility in San Diego, California. As we look forward to our upcoming facility expansions, which will feature multiple 2,000L single-use bioreactors, we remain dedicated to meeting the growing needs of our customers and advancing biopharmaceutical solutions. I want to thank our exceptional teams in the U.S. and Taiwan, and our valued customers, for their continued support.”
Now in its 14th year, the Outsourced Pharma’s CDMO Leadership Awards introduced new categories and an enhanced scoring methodology, developed in collaboration with its research partner, Orientation Marketing.
About Bora Pharmaceuticals
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products. From our world-class sites in North America and Asia, we deliver drug products with unparalleled quality to more than 100 markets around the world.
